Vc
1890
First documented case of lung cancer
Initial recognition of the disease as a distinct clinical entity.
Various clinicians
Explore / Oncology / Pulmonology
1 explorers / 4 open questions / 0 papers
Lung cancer is a malignancy arising from the bronchial epithelium or glandular tissue of the lungs. It is broadly categorized into Small Cell Lung Cancer (SCLC), which is aggressive and highly associated with smoking, and Non-Small Cell Lung Cancer (NSCLC), which includes adenocarcinoma and squamous cell carcinoma. Diagnosis typically involves imaging (CT/PET) and histological confirmation via biopsy.
Known nodes connect to ghost nodes where questions remain open.
Credit follows documented contributions. Open questions remain attached to the historical path rather than being presented as context-free prompts.
1890
First documented case of lung cancer
Initial recognition of the disease as a distinct clinical entity.
Various clinicians
1950
Link between smoking and lung cancer established
Large-scale epidemiological study proving the causal link.
Doll and Hill
2004
Approval of first targeted therapy (Gefitinib)
Shift toward precision medicine targeting EGFR mutations.
AstraZeneca
2015
FDA approval of Pembrolizumab
Introduction of PD-1 inhibitors for immune-mediated tumor destruction.
Merck
Open questions
How can we overcome acquired resistance to third-generation EGFR inhibitors in NSCLC?
1 researchers / 0 stakes
Open research workspace
What are the precise epigenetic triggers for lung cancer in lifelong non-smokers?
1 researchers / 0 stakes
Open research workspace
Can liquid biopsies reliably detect minimal residual disease (MRD) before radiological recurrence?
1 researchers / 0 stakes
Open research workspace
How does the lung microbiome influence the efficacy of immunotherapy?
1 researchers / 0 stakes
Open research workspace
Ghost nodes
Can liquid biopsies reliably detect minimal residual disease (MRD) before radiological recurrence?
khuffu / 1 active
Canonicalized from an unresolved question attached to this concept.
openHow can we overcome acquired resistance to third-generation EGFR inhibitors in NSCLC?
khuffu / 1 active
Canonicalized from an unresolved question attached to this concept.
openHow does the lung microbiome influence the efficacy of immunotherapy?
khuffu / 1 active
Canonicalized from an unresolved question attached to this concept.
openWhat are the precise epigenetic triggers for lung cancer in lifelong non-smokers?
khuffu / 1 active
Canonicalized from an unresolved question attached to this concept.